AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 DEC 19 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Intensive efforts to attain a 90% hepatitis B virus (HBV) vaccine rate among children has fallen short, according to investigators at the U.S. Centers for Disease Control and Prevention (CDC).
In the past ten years, an initiative to increase the number of infants receiving the three dose HBV vaccine series (HepB3) before the age of 18 months has improved infant vaccine rates, but those rates have been begun to level off and not continued to rise as fast, H. Yusef of the National Immunization Program and other CDC collaborators recently reported.
Ten years ago, a panel of experts from the Advisory Committee on Immunization Practices recommended that infants receive the first dose of the triple-dose vaccine shortly after birth and the other two doses at recommended intervals before the second birthday. Since that time, U.S. pediatricians have embraced that recommendation. Yet, data from an exhaustive survey of vaccine practices begun in 1994, called the National Immunization Survey, reveals some regions of the U.S fall short on that policy.
"The 1999 National Survey data indicate that approximately 88.1% (95% CI, 87.4, 88.8) of children 19 to 35 months of age had received at least three doses of HepB3," Yusef and team said.
Despite better vaccine ...
Source: HighBeam Research, Despite Efforts, Pediatric Hepatitis B Vaccine Rates Don't Meet...